ClinicalTrials.Veeva

Menu

Incidence Of Hepatitis In Intensive Care Unit

S

Sakarya University

Status

Unknown

Conditions

Intensive Care Unit

Treatments

Other: hepatitis viruses

Study type

Observational

Funder types

Other

Identifiers

NCT03456037
hepatitis

Details and patient eligibility

About

The aim is to investigate incidence of HBsAg, anti-HCV in serum samples and evaluation of biomarkers taken from patients who were followed the intensive care unit of Sakarya University Training and Research Hospital and The intensive care unit attracts attention by making health workers more susceptible to the risk of hepatitis.

Full description

This retrospective study included 536 cases who were followed with various diagnoses in intensive care units between 1 Ocak 2015 ile 1 Ocak 2016, covering the six months period, retrospectively. Sakarya University's Faculty of Medicine Review Board (71522473/050.01.04/113) approved the study after approval of the research ethics committee (. Medical record forms and electronic medical record system of the hospital were used in the analysis of medical data with regard to age, sex, HBsAg, anti-HCV, AST, ALT, bilirubin, creatinine levels.

Enrollment

500 estimated patients

Sex

All

Ages

18 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All patients who were followed in the intensive care unit

Exclusion criteria

None

Trial contacts and locations

1

Loading...

Central trial contact

Havva Sayhan,, Assis Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems